These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33624331)
21. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation. Deguchi I; Tanahashi N; Takao M J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321 [TBL] [Abstract][Full Text] [Related]
22. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833 [TBL] [Abstract][Full Text] [Related]
23. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation. Kido K; Ngorsuraches S Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979 [TBL] [Abstract][Full Text] [Related]
24. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease. Kampouraki E; Kamali F Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328 [TBL] [Abstract][Full Text] [Related]
25. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015. Alamneh EA; Chalmers L; Bereznicki LR Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198 [TBL] [Abstract][Full Text] [Related]
26. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation? Anderson SL; Marrs JC Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836 [TBL] [Abstract][Full Text] [Related]
27. Trends in anticoagulant prescribing: a review of local policies in English primary care. Ho KH; van Hove M; Leng G BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380 [TBL] [Abstract][Full Text] [Related]
28. Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation. Ferroni E; Gennaro N; Costa G; Fedeli U; Denas G; Pengo V; Corti MC Int J Cardiol; 2019 Aug; 288():72-75. PubMed ID: 31043323 [TBL] [Abstract][Full Text] [Related]
29. An Update on Anticoagulation in Atrial Fibrillation. Amerena J; Ridley D Heart Lung Circ; 2017 Sep; 26(9):911-917. PubMed ID: 28684097 [TBL] [Abstract][Full Text] [Related]
30. Direct oral anticoagulants: unique properties and practical approaches to management. Barnes GD; Kurtz B Heart; 2016 Oct; 102(20):1620-6. PubMed ID: 27402803 [TBL] [Abstract][Full Text] [Related]
31. When and how to use direct oral anticoagulants in patients with advanced chronic liver disease? De Maria C; Galante A; Fasoli A; De Gottardi A Curr Opin Pharmacol; 2021 Oct; 60():111-116. PubMed ID: 34403992 [TBL] [Abstract][Full Text] [Related]
32. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention. Hirano T; Kaneko H; Mishina S; Wang F; Morita S J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411 [TBL] [Abstract][Full Text] [Related]
34. Newer and Better? Comparing Direct Oral Anticoagulants to Warfarin in Patients With Traumatic Intracranial Hemorrhage. Billings JD; Khan AD; McVicker JH; Schroeppel TJ Am Surg; 2020 Sep; 86(9):1062-1066. PubMed ID: 33049165 [TBL] [Abstract][Full Text] [Related]
35. [New direct oral oral anticoagulants (DOACs) - indications of DOACs]. Darius H Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238 [TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control. Janzic A; Kos M Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096 [TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study. Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A; CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273 [TBL] [Abstract][Full Text] [Related]
38. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa. Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565 [TBL] [Abstract][Full Text] [Related]
39. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation. Mtwesi V; Amit G Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330 [TBL] [Abstract][Full Text] [Related]
40. Direct Oral Anticoagulants in Chronic Liver Disease. Steuber TD; Howard ML; Nisly SA Ann Pharmacother; 2019 Oct; 53(10):1042-1049. PubMed ID: 30947523 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]